trial profile
DESCRIPTION
Trial profile. Fox K et al. Lancet 2008;372:807-16. Baseline characteristics. Fox K et al. Lancet 2008;372:807-16. Baseline characteristics of the subgroup with heart rate of 70 bpm or greater. Fox K et al. Lancet 2008;372:807-16. - PowerPoint PPT PresentationTRANSCRIPT
Trial profile
Fox K et al. Lancet 2008;372:807-16
Baseline characteristics
Fox K et al. Lancet 2008;372:807-16
Baseline characteristics of the subgroup with heart rate of 70 bpm or greater
Fox K et al. Lancet 2008;372:807-16
Mean heart rate during the study (A) in the total study population and (B) in the subgroup
with heart rate of 70 bpm or greater
Fox K et al. Lancet 2008;372:807-16
Incidence of serious adverse events during the study by system organ class
Fox K et al. Lancet 2008;372:807-16
Primary and secondary endpoints
Fox K et al. Lancet 2008;372:807-16
Kaplan–Meier time-to-event plot, by treatment group for composite primary endpoint in the total study population
Fox K et al. Lancet 2008;372:807-16
Effect of treatment on composite primary endpoint in prespecified subgroups
Fox K et al. Lancet 2008;372:807-16
Kaplan–Meier time-to-event plot, by treatment group in the prespecified subgroup with heart rate of
70 bpm or greater for composite primary endpoint
Fox K et al. Lancet 2008;372:807-16
Kaplan–Meier time-to-event plots, by
treatment group in the prespecifi ed subgroup
with heart rateof 70 bpm or greater,
for the secondary endpoints of (A)
admission to hospital for new-onset or
worsening heart failure and (B) cardiovascular
death or admission to hospital for new-onset or worsening
heart failure
Fox K et al. Lancet 2008;372:807-16
Kaplan–Meier time-to-event plots, by
treatment group in the prespecifi ed subgroup
with heart rateof 70 bpm or greater
for the secondary endpoints of (A)
admission to hospital for acute myocardial
infarction endpoint and (B) admission to hospital for acute
myocardial infarction or unstable angina
Fox K et al. Lancet 2008;372:807-16
Kaplan–Meier time-to-event plot, by treatment group in the prespecified subgroup with heart rate of 70 bpm or greater
for secondary endpoint of coronary revascularisation
Fox K et al. Lancet 2008;372:807-16